Search for: "SCHERING-PLOUGH" Results 41 - 60 of 404
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2013, 9:00 pm by Nietzer
The Schering-Plough SEC Complaint listed several items which it deemed indicia of red flags. 1. [read post]
23 Jan 2013, 4:16 pm by Lawrence B. Ebert
Schering-Plough Corp., 320 F.3d 1339, 1345 (Fed.Cir. 2003). [read post]
5 Nov 2012, 12:10 pm
Those cases are filed against Merck, which merged with Schering-Plough in 2009, which itself merged with Organon in 2007. [read post]
24 Oct 2012, 10:02 am by Tom Lamb
Since that time, first, Organon was acquired by Schering-Plough and, later, Merck took over Schering-Plough and Organon. [read post]
3 Oct 2012, 11:00 am by Tom Lamb
Since that time, first, Organon was acquired by Schering-Plough and, later, Merck took over Schering-Plough and Organon. [read post]
26 Sep 2012, 12:00 pm by AnnMarie McDonald
”  Originally developed by Schering-Plough, Merck acquired Coppertone (and its lawsuit) when it bought Schering in 2009. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
   Schering also sued ESI for infringement, but ESI countered that its version was not the same as Schering’s. [read post]
31 Jul 2012, 7:25 am by aschwartz
  Per the settlements, Upsher Smith and ESI agreed not to market their generic versions until September 1, 2001, which was some years prior to the expiration of Schering-Plough’s patents. [read post]
26 Jul 2012, 1:12 pm
Rob retained an attorney to file a complaint against the ring’s manufacturers, Organon, and Schering-Plough, who are now a part of Merck. [read post]
19 Jul 2012, 1:17 pm by Bexis
  Moreover, given the Third Circuit’s intervening standing decision in In re Schering Plough Corp. [read post]
19 Jul 2012, 1:17 pm by Bexis
  Moreover, given the Third Circuit’s intervening standing decision in In re Schering Plough Corp. [read post]
16 Jul 2012, 1:18 pm by Jeffrey May
The appellate court decided that wholesalers and retailers who purchased a brand-name sustained-release potassium chloride supplement (K-Dur) used to treat high blood pressure could proceed with an antitrust challenge  to patent infringement litigation settlement agreements between Schering-Plough Corporation — the manufacturer of K-Dur — and generic drug companies. [read post]